Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,187.65
+0.65 (0.05%)
At close: Oct 6, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 164.36 billion as of October 7, 2026. Its market cap has decreased by -24.26% in one year.
Market Cap
164.36B
Enterprise Value
187.21B
Revenue
32.12B
Ranking
n/a
PE Ratio
25.53
Stock Price
1,187.65
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 164.36B, an increase of 98.73%. That is a compound annual growth rate of 7.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 164.36B | -19.86% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 335.30B |
| Piramal Pharma | 259.06B |
| Cohance Lifesciences | 170.93B |
| Alivus Life Sciences | 168.61B |
| Eris Lifesciences | 164.90B |
| Alembic Pharmaceuticals | 163.39B |
| NATCO Pharma | 147.52B |
| Sudeep Pharma | 132.53B |